No products in the cart.
Return To ShopNo products in the cart.
Return To ShopNo products in the cart.
Return To Shopanabolicdirectplus.com
No products in the cart.
Return To Shop€52.00
ABILIFY, produced by Bristol-Myers Squibb, is an atypical antipsychotic primarily used to treat conditions such as schizophrenia and bipolar disorder. The active ingredient, aripiprazole, works by modulating the activity of neurotransmitters like dopamine and serotonin in the brain. In sports pharmacology, ABILIFY is sometimes explored for its potential effects on psychological performance and focus, which may indirectly benefit athletes. While it is not a conventional performance-enhancing drug, understanding its mechanism of action can provide insight into its possible influences on sports performance and mental health.
The physiological effects of ABILIFY are primarily linked to its action on neurotransmitter receptors. By stabilizing dopamine levels, it may help maintain a balance that fosters improved mood and reduces anxiety, zoning in on crucial mental states that athletes often strive for. Enhanced focus can translate to better training sessions, improved consistency in performance, and effective coping mechanisms in competitive scenarios. Moreover, athletes dealing with conditions such as depression or anxiety might find relief in their symptoms with the help of ABILIFY, allowing them to optimize their engagement in sports. However, the medication does not directly enhance physical abilities like strength or endurance, and its psychological benefits should be viewed within the context of a comprehensive mental health strategy.
As with any medication, monitoring for side effects when using ABILIFY is essential. Common side effects can include drowsiness, nausea, and restlessness. In athletes, these side effects may impact training by causing fatigue or distraction. More serious risks could involve metabolic changes, potential weight gain, and movements disorders which could hinder athletic performance. Athletes considering ABILIFY must engage in open discussions with healthcare providers to ensure that they weigh potential benefits against risks. Regular monitoring is strongly advised, especially during the initial stages of treatment, to monitor how the body responds. Labs might check metabolic parameters to ensure safety and efficacy during its usage.
Purchasing ABILIFY 10 mg can be done through a licensed pharmacy with a valid prescription from a healthcare provider. It’s crucial for athletes to obtain this medication under medical supervision, ensuring legitimacy and quality. Many pharmacies offer online services, making it convenient for users to secure their medication while ensuring privacy and discretion. Additionally, legitimate vendors will provide customer support and a guarantee of the authenticity of the drug, which is vital for the safety of users. Before making a purchase, individuals should verify the pharmacy’s credentials, ensuring they comply with health regulatory standards to safeguard against counterfeit products.
Overall, ABILIFY 10 mg by Bristol-Myers Squibb holds a unique position within the realm of sports pharmacology, particularly when considering mental health aspects crucial for athletic performance. While it does not enhance physical capabilities, its ability to improve psychological resilience can be beneficial to athletes managing mental health conditions. However, prospective users must remain vigilant regarding potential side effects, treating the medication with the caution it deserves. Ultimately, the safe utilization of ABILIFY hinges on thorough discussions with healthcare professionals, ensuring that athletes can prioritize both their mental well-being and athletic pursuits. In a sport-centric context, ABILIFY should be considered a part of a broader approach to mental health, rather than solely a performance-enhancing solution.
| Raw Material | Aripiprazol |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Monitoring blood levels is not typically required, but lipid profiles, blood glucose, and weight should be monitored |
| Also known as | OPC-14597, OPC-31 |
| Blood pressure | Can cause orthostatic hypotension |
| Trade name | Abilify, Aripiprex |
| Storage conditions | Store at room temperature, 15-30В°C (59-86В°F) |
| Chemical name | 7-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one |
| Formula | C23H27Cl2N3O2 |
| Substance class | Atypical antipsychotic |
| Main action | Dopamine D2 and serotonin 5-HT1A receptor partial agonist |
| Half-life | Approximately 75 hours |
| Dosage (medical) | Typically starts at 10-15 mg once daily for schizophrenia, 2-15 mg once daily for bipolar disorder |
| Dosage (sports) | Not applicable |
| Effects | Antipsychotic, mood stabilization, reducing symptoms of schizophrenia and bipolar disorder |
| Side effects | Anxiety, insomnia, nausea, vomiting, blurred vision, somnolence, restlessness, tremor |
| Use in sports | None |
| Manufacturer | Bristol – Myers Squibb |
| Packing | 28 tabs (10 mg/tab) |
€69.00
Select at least 2 products
to compare
Reviews
There are no reviews yet.